Newsroom

At Quibim, we see imaging as more than pictures; to us, it’s a powerful catalyst for precision health. Our ambition is to transform each image into a source of deep insights, charting the course for personalized healthcare solutions.

We unlock new data by applying AI techniques to medical images from MRI, CT, and PET scans, transforming them into actionable predictions for life sciences and healthcare providers. Our pioneering solutions extend beyond mere data analysis; they are at the heart of our mission, turning each image into a comprehensive roadmap for enhanced patient treatment and care.

Leading a transformation in healthcare, Quibim is not just about advancing technology; it’s about redefining healthcare and improving lives. Our journey is about discovery and innovation, driven by a commitment to use the power of medical imaging to reshape the healthcare landscape.

Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers. The business model is based on a platform marketed through SaaS for hospitals and value-based partnerships in life sciences that help to identify new market needs and create new algorithms.

After years of intense research in imaging biomarkers, Quibim (QUantitative Imaging Biomarkers In Medicine) did the commercial launch and internationalization in 2021. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers. The business model is based on a platform marketed through SaaS for hospitals and value-based partnerships in life sciences that help to identify new market needs and create new algorithms.

Having expanded internationally and with a growing team, we are now heading up to bring a new line of products based on predictive imaging biomarker panels.